HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wang, J. B. Articles by Uhl, G. R. Search for Related Content PubMed PubMed Citation Articles by Wang, J. B. Articles by Uhl, G. R. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 269, Issue 42, 25966-25969, Oct, 1994

Human kappa opiate receptor second extracellular loop elevates dynorphin's affinity for human mu/kappa chimeras

JB Wang, PS Johnson, JM Wu, WF Wang and GR Uhl
Molecular Neurobiology Branch, National Institute on Drug Abuse, Baltimore, Maryland.

To investigate roles of second extracellular loop sequences in peptide and nonpeptide ligand recognition by human opiate receptors, we have constructed a chimeric receptor in which this domain of the human mu opiate receptor has been replaced with that of the human kappa opiate receptor. The chimeric opiate receptor displays dramatically increased affinity for dynorphin peptides. Affinities for dynorphin A-(1-17), dynorphin A-(1-13), and alpha-neoendorphin increase by up to 250-fold when compared with the wild-type human mu opiate receptor. The chimera maintains recognition of the mu-selective ligands morphine and [D- Ala2,MePhe4,Gly-ol5]enkephalin and displays no significant changes in affinity for the kappa-selective small molecule ligand U50,488. The chimeric opiate receptor displays evidence for effective G-protein coupling; 100 nM dynorphin A-(1-17) is as effective as 100 nM morphine at inhibiting forskolin-stimulated adenyl cyclase activity through actions at the chimeric receptor. These data suggest that the putative second extracellular loop contributes substantially to the kappa receptor's selectivity in dynorphin ligand recognition.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				C S. Bradford, E. A Walthers, B. T Searcy, and F. L Moore Cloning, heterologous expression and pharmacological characterization of a kappa opioid receptor from the brain of the rough-skinned newt, Taricha granulosa J. Mol. Endocrinol., June 1, 2005; 34(3): 809 - 823. [Abstract] [Full Text] [PDF]

				D. Ott, R. Frischknecht, and A. Pluckthun Construction and characterization of a kappa opioid receptor devoid of all free cysteines Protein Eng. Des. Sel., January 1, 2004; 17(1): 37 - 48. [Abstract] [Full Text] [PDF]

				C. E. Owens and H. Akil Determinants of Ligand Selectivity at the kappa -Receptor Based on The Structure of the Orphanin FQ Receptor J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 992 - 999. [Abstract] [Full Text] [PDF]

				M. Filizola, L. Laakkonen, and G. H. loew 3D modeling, ligand binding and activation studies of the cloned mouse {delta}, {micro} and {kappa} opioid receptors Protein Eng. Des. Sel., November 1, 1999; 12(11): 927 - 942. [Abstract] [Full Text] [PDF]

				J. A. J. Becker, A. Wallace, A. Garzon, P. Ingallinella, E. Bianchi, R. Cortese, F. Simonin, B. L. Kieffer, and A. Pessi Ligands for kappa -Opioid and ORL1 Receptors Identified from a Conformationally Constrained Peptide Combinatorial Library J. Biol. Chem., September 24, 1999; 274(39): 27513 - 27522. [Abstract] [Full Text] [PDF]

				C. Mollereau, L. Mouledous, S. Lapalu, G. Cambois, C. Moisand, J.-L. Butour, and J.-C. Meunier Distinct Mechanisms for Activation of the Opioid Receptor-Like 1 and kappa -Opioid Receptors by Nociceptin and Dynorphin A Mol. Pharmacol., February 1, 1999; 55(2): 324 - 331. [Abstract] [Full Text]

				F. Meng, Y. Ueda, M. T. Hoversten, L. P. Taylor, R. K. Reinscheid, F. J. Monsma, S. J. Watson, O. Civelli, and H. Akil Creating a Functional Opioid Alkaloid Binding Site in the Orphanin FQ Receptor through Site-Directed Mutagenesis Mol. Pharmacol., April 1, 1998; 53(4): 772 - 777. [Abstract] [Full Text]

				A. J. Mandell, K. A. Selz, and M. F. Shlesinger Mode matches and their locations in the hydrophobic free energy sequences of peptide ligands and their receptor eigenfunctions PNAS, December 9, 1997; 94(25): 13576 - 13581. [Abstract] [Full Text] [PDF]

				F. Meng, L. P. Taylor, M. T. Hoversten, Y. Ueda, A. Ardati, RainerK. Reinscheid, FrederickJ. Monsma, StanleyJ. Watson, O. Civelli, and H. Akil Moving from the Orphanin FQ Receptor to an Opioid Receptor Using Four Point Mutations J. Biol. Chem., December 13, 1996; 271(50): 32016 - 32020. [Abstract] [Full Text] [PDF]

				C. Chen, J. Yin, J. K. d. Riel, R. L. DesJarlais, L. F. Raveglia, J. Zhu, and L.-Y. Liu-Chen Determination of the Amino Acid Residue Involved in [3H]beta -Funaltrexamine Covalent Binding in the Cloned RatµOpioid Receptor J. Biol. Chem., August 30, 1996; 271(35): 21422 - 21429. [Abstract] [Full Text] [PDF]

				G. Liapakis, D. Fitzpatrick, C. Hoeger, J. Rivier, R. Vandlen, and T. Reisine Identification of Ligand Binding Determinants in the Somatostatin Receptor Subtypes 1and 2 J. Biol. Chem., August 23, 1996; 271(34): 20331 - 20339. [Abstract] [Full Text] [PDF]

				S. Silvente-Poirot and S. A. Wank A Segment of Five Amino Acids in the Second Extracellular Loop of the Cholecystokinin-B Receptor Is Essential for Selectivity of the Peptide Agonist Gastrin J. Biol. Chem., June 21, 1996; 271(25): 14698 - 14706. [Abstract] [Full Text] [PDF]

				K. Befort, L. Tabbara, D. Kling, B. Maigret, and B. L. Kieffer Role of Aromatic Transmembrane Residues of the [IMAGE]-Opioid Receptor in Ligand Recognition J. Biol. Chem., April 26, 1996; 271(17): 10161 - 10168. [Abstract] [Full Text] [PDF]

				K. Thirstrup, C. E. Elling, S. A. Hjorth, and T. W. Schwartz Construction of a High Affinity Zinc Switch in the kappa-Opioid Receptor J. Biol. Chem., April 5, 1996; 271(14): 7875 - 7878. [Abstract] [Full Text] [PDF]

				M. Shahrestanifar, W. W. Wang, and R. D. Howells Studies on Inhibition of µ and [IMAGE] Opioid Receptor Binding by Dithiothreitol and N-Ethylmaleimide J. Biol. Chem., March 8, 1996; 271(10): 5505 - 5512. [Abstract] [Full Text] [PDF]

				J. Zhu, J. Yin, P.-Y. Law, P. A. Claude, K. C. Rice, C. J. Evans, C. Chen, L. Yu, and L.-Y. Liu-Chen Irreversible Binding of cis-(+)-3-Methylfentanyl Isothiocyanate to the [IMAGE] Opioid Receptor and Determination of Its Binding Domain J. Biol. Chem., January 19, 1996; 271(3): 1430 - 1434. [Abstract] [Full Text] [PDF]

				C. Chen, J.-C. Xue, J. Zhu, Y.-W. Chen, S. Kunapuli, J. K. d. Riel, L. Yu, and L.-Y. Liu-Chen Characterization of Irreversible Binding of [IMAGE]-Funaltrexamine to the Cloned Rat µ Opioid Receptor J. Biol. Chem., July 28, 1995; 270(30): 17866 - 17870. [Abstract] [Full Text] [PDF]

				F. Meng, M. T. Hoversten, R. C. Thompson, L. Taylor, S. J. Watson, and H. Akil A Chimeric Study of the Molecular Basis of Affinity and Selectivity of the [IMAGE] and the [IMAGE] Opioid Receptors J. Biol. Chem., May 26, 1995; 270(21): 12730 - 12736. [Abstract] [Full Text] [PDF]